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Preface
Stroke is the most common life threatening neurological disease and is the third leading 
cause of death in the United States after heart disease and cancer. However stroke is 
considered to be more disabling than lethal and is a catastrophic event for both the patient 
and his relatives. It is not unusual for a previously normal intelligent person to be rendered 
aphasic, paralysed and incontinent. Much interest has focused on the therapy of stroke but it 
should be considered that prevention is far superior to a cure. Indeed prevention of stroke 
by the treatment of modifiable atherogenic host and environmental risk factors is likely to be 
the most effective means of reducing morbidity and mortality in this fatal condition. Factors 
such as antihypertensive therapy, cessation of cigarette smoking, reduction in alcohol 
consumption and control of serum cholesterol, constitute realistic measures which could 
prevent the occurrence of atherothrombotic stroke. However despite avid attempts to 
prevent stroke, in reality it is still a common pathological event and a major health problem. 
As such pre-clinical research into the pathophysiology of stroke, utilising both in vitro and in 
vivo  techniques has been accelerated over the past few decades. It is accepted that 
physiologically regulated reproducible animal models must be utilized to gain insight into the 
very complex pathology of cerebral ischaemia and to investigate potential therapeutic 
strategies.
However in an era of aggressive animal rights activism it has been proposed that advances in 
technology capable of deriving morphological, physiological and even metabolic data from 
patients should permit animal testing and experimentation into cerebral ischaemia to be scaled 
down. Nevertheless, there are many fundamental issues that cannot be addressed in humans 
and therapeutic strategies must be investigated at a basic level for both efficacy and toxicity 
before moving to the clinical arena. The advantages of animal models of cerebral ischaemia 
are numerous and have been discussed in detail in section 1.6 of this thesis. This thesis also 
discusses the complex and divergent biochemical events proposed to be involved in the 
ischaemic cascade and attempts to emphasis that the glutamate theory of ischaemic cell death 
although important, does not contain all the answers. A vast array of experimentation has 
been performed within the scientific community to reach the present level of knowledge but 
in my opinion the most exciting advances in ischaemic research came with the revelation that 
the m ajority of human embolic strokes in general involve some degree of vessel 
recanalization and spontaneous reperfusion. This heralded the beginning of research into 
post-ischaemic reperfusion. Subsequent reports have implicated that the restoration of 
cerebral blood flow following an ischaemic event may have a dark side whereby delayed or 
late reperfusion is paradoxically detrimental to the final outcome.
The aim of this PhD thesis was to investigate the consequences of reperfusion on cerebral 
ischaemic damage. Ultimately, this required the use of an appropriate animal model of 
transient focal cerebral ischaemia and the endothelin reperfusion model fulfilled this role.
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It incorporates a period of ischaemia within middle cerebral artery (MCA) territory followed 
by a gradual reperfusion. Of particular interest to me was the profile of cerebral blood flow 
(CBF) changes following endothelin-1 application to the MCA. There is much discussion in 
this thesis on the regulation and control of CBF with particular reference to endogenous 
mediators of cerebrovascular homeostasis. A discussion on the numerous techniques 
available for both clinical and pre-clinical assessment of CBF highlighted the importance of 
autoradiographic procedures in pre-clinical research involving animal experimentation. As 
such a novel double label autoradiography technique was developed within our laboratory. 
The practical aspects and utility of the procedure were subsequently investigated by myself 
and the outcome reported in this thesis.
The work presented in this thesis also intended to address certain fundamental issues 
pertinent to the characterisation of post-ischaemic reperfusion. Studies were designed and 
information obtained on the consequences of reperfusion on brain swelling and oedema 
formation, microvascular permeability and at the cellular level, on neurotransmitter 
transduction systems and second messengers. Of fundamental importance to the pathology 
of reperfusion injury is the contribution that free radical damage makes to the overall 
cascade. The role free radicals play in this process is discussed in detail and the results of 
an investigation into the neuroprotective effects of the glutathione peroxidase mimic ebselen 
reported. Thus the content of this PhD thesis is of interest from both a mechanistic and 
therapeutic angle. The ultimate aim of pre-clinical research is to propel effective and safe 
therapeutic strategies into the clinic. However to focus entirely on this angle of ischaemic 
research because it is presently in vogue would be naive. Of equal importance is research 
aimed at characterising fully the complex mechanisms contributing to the pathology of both 
cerebral ischaemia and reperfusion injury. We fully appreciate the enormity of this task and 
meet the challenge with enthusiasm. I propose that the content of this PhD thesis contributes 
to the vast array of information currently available and paves the way for future research into 
the exciting field of post ischaemic reperfusion and reperfusion injury.
D eclaration
This thesis comprises my own original work and has not been presented previously as a 
thesis in any form. Certain experiments were carried out in collaboration with other 
researcher. Mr. P. Bannan, an experienced neurosurgeon, carried out the permanent middle 
cerebral artery (MCA) occlusion in the cat (section 3.1). The permanent MCA occlusion 
carried out in the rat (section 3.2) was performed by Dr. M. McAuley and the transient MCA 
occlusion induced by ET-1 application to the MCA reported in sections 3.3 (study 1) and 3.5 
was performed by Dr. D. Dawson. In each case all additional experimental procedures 
excluding MCA occlusion and all analysis of results were carried out by myself. In all other 
studies reported in thesis MCA occlusion was carried out by myself.
Summary
The aim o f this PhD thesis was to investigate the consequences of reperfusion on cerebral 
ischaemic damage using a new model of transient focal cerebral ischaemia developed at the 
Wellcome Surgical Institute. The model involves the abluminal application of the potent 
vasoconstrictor peptide endothelin-1 (ET-1) to the exposed MCA of the anaesthetised rat. 
Previous studied using the hydrogen clearance CBF technique and quantitative 
autoradiographic and histopathological procedures, revealed that ET-1 application to the 
MCA produced a profound ischaemia followed by a gradual, spontaneous reperfusion 
resulting in a reproducible lesion (within the cortex and caudate nucleus) by 4h post insult. 
The object of this thesis was to further characterise the pathological mechanisms associated 
with this model of transient cerebral ischaemia by investigating such parameters as CBF, 
brain tissue swelling, microvascular permeability, free radical damage and neurotransmitter 
transduction systems and second messengers.
Characterisation of CBF profile
A novel double label CBF autoradiography technique was utilised to investigate the CBF 
profile following ET-1 induced transient cerebral ischaemia. The CBF tracers 99mTc- 
hexamethylpropyleneamine oxime (HMPAO) and 14C-iodoantipyrine (IAP) were used to 
provide a topographic profile of CBF at two distinct time points in the same animal. 
Previous work demonstrated that 99mTc-HMPAO is inherently unstable in the vial after 
reconstitution, and a 30min shelf life was therefore recommended. It was demonstrated in 
this thesis that the addition of cobalt chloride hexahydrate to the reconstituted vial can extend 
the in vitro shelf life to at least 4h post reconstitution. The addition of the stabiliser does not 
alter the ability of 99mTc-HMPAO to image CBF and does not have any influence on the 
absolute CBF in the cat.
In this cat study and in a separate rat study, 99mTc-HMPAO was shown to underestimate 
absolute CBF (assessed with 14C-IAP) in high flow areas of the brain due to back diffusion 
from brain to blood. This well known phenomenon attributed to the complex in vivo 
kinetics of 99mTc-HMPAO was previously demonstrated by comparison with other CBF 
tracers. The complex in vivo kinetics of 99mTc-HMPAO may also be responsible for the 
apparent discrepancy noted between normalised 14C-IAP and 99mTc-HMPAO in low and 
normal flow areas when administered 2min apart. Indeed " mTc-HMPAO may overestimate 
flow in these areas but the possibility of 14C-IAP underestimating flow should also be 
considered. This study highlighted the importance of the double label CBF autoradiography 
technique for providing topographic profiles of CBF and emphasises that the discrepancy 
between tracers should not pose a restriction to the use of the technique providing it is 
considered when interpreting results.
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Subsequent studies utilised the double label autoradiography technique to investigate the 
topographic profile of reperfusion into ischaemic tissue following ET-1 induced reversible 
MCA occlusion. Blood flow changes were assessed with 99mTc-HMPAO during ischaemia 
(5min) and 14C-IAP during reperfusion (initially at 2h and then at 30min, 1 h, 2h and 4h post 
insult in a subsequent study). Following a significant ischaemic insult, reperfusion was 
relatively homogeneous within MCA territory but incomplete by the 4h time point. A strong 
positive correlation exists between the severity of ischaemia and subsequent reperfusion with 
evidence for differential reperfusion in the cortex and caudate nucleus and increased 
collateral supply from the anterior cerebral artery.
Brain tissue swelling
Consequent with the CBF changes during ET-1 induced ischaemia and reperfusion, there 
was a substantial ipsilateral hemispheric swelling. An exponential relationship exists 
between CBF in the parietal cortex during ischaemia and the increase in the ipsilateral 
hemispheric volume. During the first 4h post ET-1 application, swelling was maximal at the 
l-2h time points and appeared to resolve as the quality of reperfusion improved.
M icrovascular permeability
A quantitative autoradiographic technique utilising the small neutral, amino acid tracer 14C- 
aminoisobutyric acid (AIB) revealed no significant changes in the microvascular permeability 
1 and 2h post ET-1 application to the MCA, despite significant ipsilateral hemispheric 
swelling at these time points. The acute changes in brain swelling induced by ET-1 
application to the MCA, are most likely a consequence of a disturbed ion homoeostasis 
following energy failure and ion pump failure. Studies designed to investigate the 
consequences of oedema formation at later time points (e.g. 24h) following ET-1 application 
may reveal changes in microvascular permeability.
Free radical damage
Free radical formation may play a prominent role in the pathological events associated with 
post-ischaemic reperfusion. A previous study demonstrated that the Glutathione peroxidase 
mimic, Ebselen, designed to limit free radical mediated damage, is neuroprotective when 
administered 40min prior to ET-1 application to the MCA. The final study of this thesis 
revealed that Ebselen administered 15min after ET-1 application to the MCA does not reduce 
the volume of ischaemic damage and may in fact be detrimental to tissue survival. Dosing 
ebselen at various time points post ET-1 application may produce more promising results. 
Interestingly, Ebselen did not significantly influence the CBF profile in the parietal cortex 
during the first hour after administration.
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Second m essengers and neurotransmitter binding
The consequences of ET-1 induced ischaemia and reperfusion on brain injury at a cellular 
level were investigated by quantitative ligand binding autoradiography. The blood flow 
profile consistent with the ET-1 model of transient focal cerebral ischaemia was associated 
with a significant reduction in forskolin binding (a marker of the adenylate cyclase second 
messenger system) throughout MCA territory (e.g. by 25% in the parietal cortex, 11% in the 
caudate nucleus). The most marked losses in forskolin binding were in areas where 
ischaemia was severe and reperfusion poor. However, the same changes in CBF had no 
significant effect on Di dopamine receptor binding (e.g. < 2% reduction in caudate nucleus). 
Thus, ligand binding characteristics are significantly affected as early as 2h post insult, with 
evidence of differential sensitivity for forskolin and Di dopamine binding. Comparison with 
the results of a study investigating the consequences of maintained ischaemia on these 
systems revealed reperfusion-related salvage of dopamine and forskolin binding in the 
caudate nucleus but possible exacerbation of forskolin binding loss in the cortex.
xxi
Part 1 - Introduction
1.1 Cerebrovascular disease in man - an overview
Stroke - "the rapid development o f  clinical signs o f a focal (or global) 
disturbance o f  cerebral function with symptoms lasting 24 
hours or longer or which leads to death with no apparent cause 
other than o f  vascular origin”
World Health Organisation 1988
Acute cerebrovascular disease (synonymous with "cerebrovascular accident" or "stroke') is a 
major public health problem in most parts of the world. Despite modem advances in the 
management strategies of cerebrovascular disease, stroke is still a major cause of mortality 
and disability. About half of all individuals who survive a stroke have significant persisting 
neurological impairment and physical disability. In individual cases the immediate outlook 
for life depends on several factors, such as age of the patient and the type, size and 
anatomical site of the cerebrovascular lesion. The type of lesion influences not only the 
ultimate outcome but also the length of the survival period. It was established over three 
decades ago that more than half of the patients who succumb to cerebral haemorrhage die 
within 2 days of the onset of the symptoms and about 80% within 2 weeks. In contrast less 
than one third of deaths due to cerebral infarction occur within a week of stroke (Brown & 
Glassenberg 1973). In addition it is apparent that a hemispheric infarct, however large, only 
becomes fatal if a secondary oedematous swelling of the brain occurs causing transtentorial 
herniation and death. It appears, therefore, that an accurate clinical diagnosis of the type and 
severity of stroke is fundamental to the management of the patient and ultimately to the 
overall prognosis. Before the various subtypes of ischaemic stroke are discussed, it is 
important to consider the vascular anatomy of the brain in order to fully appreciate the 
devastation of stroke to such a complex organ.
1.1.1 Vascular anatomy of the human brain
The general anatomical distribution in many lower species is similar to that in man and 
therefore many aspects of the following discussion may be pertinent to both rat and cat 
vascular anatomy (section 1.6).
The brain is instrumental in that it is supplied by four major arteries that eventually coalesce 
to form a structure known as the circle of Willis. These primary vessels are the two carotid 
arteries and the two vertebral arteries (which unite intracranially to form the basilar artery). 
If one of these major arteries became occluded over a prolonged period, the arrangement is 
such that the brain would still receive an adequate perfusion under normal circumstances. In
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man the carotid arteries each contribute approximately 40% of the total perfusion of the 
brain. They divide into four major branches : the anterior cerebral, the middle cerebral, the 
anterior choroidal and the posterior communicating arteries. Figure 1 illustrates the areas of 
the brain supplied by the anterior cerebral, middle cerebral and posterior cerebral arteries. 
Although this represents the situation in the majority of cases it is not absolute and there may 
be some degree of variation especially in experimental animals.
Figure 1 - Arterial distribution of brain perfusion
Anterior cerebral 
artery □ Middle cerebral artery Posterior cerebral artery
Anterior cerebral artery
Various orbital, middle and posterior branches of the anterior cerebral artery supply the 
frontal and parietal lobes. The anterior cerebral artery is also responsible for supplying the 
corpus callosum. The medial striate artery of Heubner (a large branch of the anterior 
cerebral artery) is frequently responsible for the perfusion of part of the inferior portion of 
the caudate nucleus and the most rostral portion of the putamen, in addition to the anterior 
limb of the internal capsule. It is known that the medial striate artery forms an anastomotic 
connection with the lenticulostriate arteries of the basal ganglia.
Middle cerebral arteries
The middle cerebral arteries are the major branches of the internal carotid arteries and supply 
the majority of the lateral aspects of the cerebral hemispheres. The lateral striate and 
lenticulostriate branches of the middle cerebral arteries are responsible for the perfusion of 
the putamen, globus pallidus and the internal capsule.
Anterior choroidal artery
Branches of the anterior choroidal artery supply not only the choroid plexus of the lateral 
ventricle but also cerebral structures as diverse as the optic tract, hippocampus, tract of the 
caudate nucleus, pyriform cortex, amygdala, part of the globus pallidus, the posterior limb
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of the internal capsule and particularly the middle one third of the cerebral peduncle and the 
lateral portion of the geniculate body.
Posterior communicating arteries
The bridge between the carotid and vertebrobasilar systems is formed by the posterior 
communicating arteries. A limited number of brain structures are supplied by the medial 
branches of these arteries including the genu of the corpus callosum, part of the posterior rim 
of the internal capsule, the rostral thalamus and the walls of the third ventricle.
The posterior cerebral arteries
The posterior cerebral arteries anastomose with the posterior communicating arteries to 
complete the circle of Willis. The posterior cerebral arteries are formed by a division of the 
basilar artery which itself was formed by fusion of the two vertebral arteries. The posterior 
cerebral arteries give rise to the posterior choroidal artery which supplies the choroid plexus 
of the third and lateral ventricles and in addition sends off direct branches to the thalamus. 
The posterior cerebral arteries are themselves responsible for the perfusion of part of the 
hippocampus and the thalamus.
Pial arterioles and interarteriolar anastomotic links at the cortical surface
Small pial arterioles which are the final superficial ramifications of the cerebral arteries, run 
over the surface of the brain and then enter the brain substance at various points. The mode 
of entry of these pial arterioles has been a point of great debate (Dahl 1973, Jones 1970, 
Krahn 1982). More than a century ago Heubner (1874) reported that there were extensive 
anastomotic links between arterioles and venules in the cortical surface which was in contrast 
to the minimal interarterial connections noted within the cortex. It was thought that the 
numerous anastomotic connections between the anterior, middle and posterior cerebral 
arteries on the cortical surface provided a system for redistributing blood supply. This may 
be analogous to that provided by the circle of Willis at the base of the brain but the capacity 
of the cortical anastomoses in maintaining adequate perfusion is substantially less than of the 
circle of Willis. This is highlighted by the fact that occlusion of an artery distal to the cortical 
interarteriolar anastomoses leads to severe reductions in cerebral blood flow whereas 
occlusion of an artery proximal to the circle of Willis minimally alters the basal level of flow.
Collateral circulations : arterial boundary zones
The collateral channels that exist between major cerebral arteries are of marked clinical 
importance because it is in these regions - which have been designated arterial boundary 
zones - that ischaemic brain damage may occur following an ischaemic attack. Indeed severe 
hypotension typically encountered following cardiac arrest in man leads to ischaemic brain 
damage which is frequently restricted to these arterial boundary zones. The boundary zones, 
which have also been termed border or watershed zones, appear to be localised at the 
territory limits of the major cerebral arteries (Brierly & Graham 1984). The most frequently
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affected region in the neocortex is in the depth of the parietooccipital sulci, which is at the 
limits of the fields of irrigation of the anterior, middle and posterior cerebral arteries.
M icrovascular organisation and capillary density
One of the major features of the cortical microcirculation is that arterioles penetrate the cortex 
at right angles to the surface and give rise to capillaries at all laminae. This vertical 
organisation of arterioles results in the production of minute boundary zones between 
penetrating arterioles at the distal end of the capillaries. The columnar pattern of local 
cerebral blood flow and glucose metabolism seen in the cerebral cortex during hypoxia or 
ischaemia probably reflects the orientation of these penetrating arterioles. The distribution of 
capillaries in the CNS is heterogeneous but structurally organised. It has been shown that 
the capillary density correlates with the number of synapses within a particular region 
(Dunning & W olff 1937). In addition it has been suggested that capillary density provides 
an anatomic indicator of oxidative metabolism. This theory was further supported by the 
findings that in general the brain areas that have a higher basal glucose use and blood flow 
such as the cochlear nucleus, mammillary body and cerebral cortex contain a high density of 
capillaries. Areas with lower levels of glucose use and blood flow such as the 
hypothalamus, cerebellar cortex and medullary nuclei contain fewer capillaries.
1.1.2 Classification of ischaemic stroke
Diagnosis of a specific type of stroke is more difficult than diagnosis of coronary heart 
disease because there are fewer pathognomatic laboratory tests available for stroke detection. 
The timing of the available tests such as lumbar puncture, cerebral anteriography, CT scan, 
PET or SPECT scan or non invasive studies of cerebral patency are of critical importance for 
accurate diagnosis. Even at autopsy of fatal cases it may be difficult to differentiate 
accurately between intracerebral haemorrhage, haemorrhagic infarction and subarachnoid 
haemorrhage when there has been extensive destruction of the brain and vascular structures. 
Ischaemic brain infarction may be due to thrombosis or embolism and it is often difficult to 
distinguish between the two alternatives. However in most circumstances the clinical 
features and laboratory data suffice to differentiate accurately between haemorrhage and 
infarction and in many cases classification of the ischaemic stroke into subtypes can be done 
well enough to justify the treatment strategy. In general, laboratory data indicates that large 
artery atherothrombosis infrequently causes stroke and embolism is far more common. A 
schematic diagram of the classification of stroke is shown in figure 2. This particular 
section will only deal with the classification of ischaemic stroke and will not discuss 
haemorrhagic insults.
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Infarct with large artery thrombosis
Atherosclerotic lesions (degenerative arterial changes associated with deposition of hard 
yellow plaques of lipid material in the intimal layers of the arteries) are found at bifurcations 
and curves of the larger vessels. Generally, the most severe atherothrombotic lesions are 
found in the more proximal locations of the vascular tree with primary occlusion of the 
arteries located distally over the cerebral surface being rare. Atherothrombosis can ultimately 
result in stroke by causing perfusion failure distal to the site of severe stenosis or occlusion 
of the major cerebral vessels (Hulquist 1942, Mohr 1979).
Infarct with tandem arterial pathology
In certain cases of ischaemic stroke, the sudden onset of symptoms may suggest a diagnosis 
of embolism but in contrast the angiogram may show evidence of stenosis of a major 
extracranial vessel (Edwards et al. 1979, Imparato et al. 1979). The mechanism of 
infarction in this instance complicates the differential definition of thrombus and embolus. 
As a result, a separate category of ischaemic stroke has been defined as "tandem arterial 
pathology". Embolic fragments may arise from; extracranial arteries affected by stenosis or 
ulceration, stenosis of the stem of any major cerebral artery, the basilar artery or the stump 
of an occluded internal carotid artery. A variety of mechanisms account for intracerebral 
stenosis (Little etal. 1980).
Embolism attributed to cardiac or transcardiac source
It has previously been demonstrated that embolism accounts for between 15% and 30% of 
ischaemic strokes (Kunitz et al. 1984, Mohr 1979), the majority of which occur from an 
embolus lodging in the territory of the middle cerebral artery. The size of the embolized 
material determines the site at which it initially stops in the circulation but does not determine 
its final point of airest. When the lumen diameter is too small to permit embolic material to 
pass, it will stop. This usually occurs at bifurcations or foci of atheroma at comers of the 
arteries (Adams & Fisher 1961). The use of angiography has demonstrated that mural 
thrombi and platelet aggregates are the materials most frequently embolized in the brain. 
Embolic fragments are found in the majority of cases examined angiographically within 48h 
of stroke onset but are no longer evident when the angiogram is repeated later (Mohr et al. 
1978). This would suggest that the majority of embolic strokes recanalize within the first 
few days after the initial insult. Is this beneficial or detrimental to ischaemically- 
compromised brain tissue?
It has been reported that functional prognosis is poorer if  the arterial occlusion persists 
(Kunitz et al. 1984) suggesting that reperfusion in this instance would be beneficial. 
However in general, information on the possible consequences of reperfusion into 
ischaemically compromised tissue is currently lacking. Early reperfusion through an 
occluded artery is obviously essential for the salvage of ischaemically compromised tissue 
and is known to be beneficial (Watson 1989). Delayed or late reperfusion is potentially
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deleterious and may exacerbate cellular injury induced by the preceding ischaemia, due to 
such factors as an increased production of free radicals and prostaglandins, the initiation of 
an acute inflammatory response, haemorrhagic transformation, oedema formation and brain 
swelling (Hallenbeck & Dutka 1990, Ng & Nimmannitya 1970, Omar et al. 1991, Watson 
1989). The nature of the reperfusion is another important aspect to consider (i.e. surge or 
gradual reperfusion). It has long been accepted that fragmentation and distal migration of an 
embolus will result in reperfusion of the vascular bed of ischaemic tissue perhaps 
culminating in haemorrhagic infarction (Fisher & Adams 1951). Presumably the full 
pressure of arterial blood into hypoxic capillaries results in a diapedesis of red blood cells 
through their hypoxic walls. The more intense the reperfusion the more severely damaged 
the capillary walls and the more confluent the haemorrhagic infarction. However in reality it 
is possible that reperfusion may be more gradual in nature. The most commonly 
documented means by which the lumen of a vessel is cleared of obstruction by an embolus is 
the insinuation of a column of blood between the embolus and the arterial wall. The column 
then enlarges eroding the embolus until the lumen is finally cleared. This process is 
documented to happen within hours to days after occlusion (Liebeskind et al. 1971, Zatz et 
a l  1965). At autopsy, it is common to find the vessels distended by the embolus although 
the wall is commonly histologically normal, suggesting that endothelial injury, vasospasm or 
necrotizing effects may have no role in the pathogenesis of infarction induced from 
embolism (Mohr & Barnett 1986). In addition, as it is common to find no evidence of 
haemorrhagic infarction this may suggests that surge reperfusion is the exception rather than 
the rule and reperfusion in the clinical situation is in general gradual in nature.
Infarction with normal angiogram
This diagnostic category was created to define cases with negative angiograms where there 
was no obvious cardiac or extracranial sources of ischaemic cerebral stroke. In these cases 
the CT scan is generally normal or shows low density or high density abnormalities 
consistent with haemorrhagic infarcts.
Lacunar infarcts
These infarctions are understood to reflect arterial disease of the vessels penetrating the brain 
to supply the capsule, basal ganglia, thalamus and paramedian regions of the brain stem 
(Fisher 1965). This may be caused by a tiny focus of microatheroma stenosing one of the 
deep penetrating arteries or rarely, stenosis of the middle cerebral artery.
Infarcts of undetermined cause
These may be due to :
1. Inappropriate laboratory studies
2. Inappropriate timing of the appropriate laboratory studies
3. No conclusive finding despite appropriate laboratory test and appropriate timing.
7
1.1.3 Epidem iology
Despite the fact that stroke is a major cause of morbidity and mortality, a variety of treatable 
risk factors as well as surgical and medical therapies for the primary and secondary 
prevention of stroke have been elucidated from epidemiological studies. However it is 
important to realise that the presence of a risk factor is not a prerequisite for stroke. In the 
same way, the absence of a risk factor is not a guarantee that stroke will not occur. 
Nevertheless, stroke risk factors most certainly influence the probability of stroke 
occurring (WHO/MNH Task force on stroke and other cerebrovascular disorders 1989). An 
excellent epidemiological study which documented important information on risk factors is 
the Framingham Study (Wolf et al. 1991).
Table 1 documents risk factors for atherothrombotic brain infarction (ABI) which was 
defined in the Framingham study and includes infarction secondary to large vessel 
atherothrombosis as well as lacunar infarction. According to W olf and co-workers (1992) 
ABI documented in the Framingham study comprises the most common stroke subtype 
accounting for 44% of all strokes.
1.1.4 Prevention of stroke
"When m editating over a disease, I never think o f finding  
a remedy fo r  it, but instead a means o f  preventing i t ”
Louis Pasteur 1884
Prevention of stroke by the treatment of modifiable atherogenic host and environmental risk 
factors is likely to be the most effective means of reducing morbidity and mortality in this 
fatal condition (W olf et al. 1992). Even if  risk factors are identified after a stroke, it is 
feasible that medication and surveillance may help prevent recurrence. Factors such as 
antihypertensive therapy, cessation of cigarette smoking, reduction in alcohol consumption 
and control of serum cholesterol levels should be considered as realistic measures which 
could prevent the occurrence of an atherothrombotic stroke. In addition because heart 
disease is an important precursor of stroke, prevention and treatment of coronary heart 
disease, congestive heart failure, left ventricular hypertrophy or atrial fibrillation would be 
anticipated to reduce the risk of stroke (Wolf et al. 1992).
Control of hypertension
Hypertension is the most significant risk factor associated with stroke. Indeed blood 
pressure elevation in the Framingham Study emerged as the strongest independent 
contributor to atherothrombotic stroke risk (Kannel et al. 1976). The authors stated that
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